References
- Cook GC. Persisting diarrhoea and malabsorption. Gut 1994;35: 582–6.
- Mann MD, Hill ID, Peat GM, Bowie MD. Protein and fat absorption in prolonged diarrhoea in infancy. Arch Dis Child 1982;57:268–73.
- Bennish ML, Salam MA, Wahed MA. Enteric protein loss during shigellosis. Am J Gastroenterol 1993;88:53–7.
- Bhan MK, Khoshoo V, Chowdhary D, Jain R, Raj P, Jayashree S, et al. Increased faecal alpha-1-antitrypsin excretion in children with persistent diarrhoea associated with enteric pathogens. Acta Paediatr Scand 1989;78:265–7.
- Strygler B, Nicar MJ, Santangelo WC, Porter JL, Fordtran JS. α1-Antitrypsin excretion in stool in normal subjects and in patients with gastrointestinal disorders. Gastroenterology 1990; 99:1380–7.
- Maki M, Harmoinen A, Vesikari T, Visakorpi JK. Faecal excretion of alpha-1-antitrypsin in acute diarrhoea. Arch Dis Child 1982;57:154–6.
- Thomas DW, Sinatra FR, Merritt RJ. Random faecal alpha-1-antitrypsin concentration in children with gastrointestinal disease. Gastroenterology 1981;80: 776–82.
- Mbonda E, Forget P, Saye Z, Leclercq-Foucart J. Usefulness of random fecal α1-antitrypsin and chymotrypsin determinations in children. J Pediatr Gastroenterol Nutr 1989;8: 85–8.
- Fontana M, Zuin G, Galli L, Paccagnini S, Villa M, Loguercio L. Fecal alpha-1-antitrypsin excretion in acute diarrhea: relationship with causative pathogens. Helv Paediat Acta 1988;43: 211–8.
- Dinari G, Rosenbach Y, Zahavi I, Sivan Y, Nitzan M. Random fecal α1-antitrypsin excretion in children with intestinal disorders. Am J Dis Child 1984;138: 971–3.
- Magazzu G, Jacono G, Pasquale G, Sferlazzas C, Tedeschi A, Santoro S, et al. Reliability and usefulness of random fecal α1-antitrypsin concentration: further simplification of the method. J Pediatr Gastroenterol Nutr 1985;4:402–7.
- Florent C, L’Hirondel C, Desmazures C, Aymes C, Bernier JJ. Intestinal clearance of α1-antitrypsin. Gastroenterology 1981;81: 777–80.
- Buffone GJ, Shulman RJ. Characterization and evaluation of immunochemical methods for the measurement of fecal α1-antitrypsin. Am J Clin Pathol 1985;83:326–30.
- Sugiura M, Akatsuka M, Hirano K, Sawaki S, Saito Y. Comparison of biological and immunological methods for determination of serum α1-antitrypsin. Chem Pharm Bull 1978;26: 220–5.
- Sharpstone D, Rowbottom A, Nelson M, Gazzard B. Faecal α1-antitrypsin as a marker of gastrointestinal disease in HIV antibody positive individuals. Gut 1996;38:206–10.
- Boege F, Fischbach W. Structural heterogeneity of faecal α1-antitrypsin shown by immmunoblott analysis in patients with Crohn’s disease. Gut 1991;32:496–9.
- Colombel JF, Mizon C, Balduyck M, Cortot A. Qualitative differences in faecal alpha-1-antitrypsin in patients with Crohn’s disease. Gut 1989;30:279–80.
- Mizon C, Becuwe C, Balduyck M, Colombel JF, Cortot A, Mizon J, et al. Qualitative study of fecal α1-proteinase inhibitor in normal subjects and patients with Crohn’s disease. Clin Chem 1988;34:2268–70.
- Mancini G, Carbonara CO, Heremans JF. Immunochemical quantitation of antigens by radial immunodiffusion. Immuno-chemistry 1965;2:235–54.
- Ganrot PO. Crossed immunoelectrophoresis. Scand J Clin Lab Invest 1972;29 Suppl 124:39–41.
- Alam AN, Sarker SA, Wahed MA, Khatun M, Rahaman MM. Enteric protein loss and intestinal permeability changes in children during acute shigellosis and after recovery: effect of zinc supplementation. Gut 1994;35:1707–11.
- Sullivan PB, Lunn PG, Northrop-Clewes CA, Farthing MJG. Parasitic infection of the gut and protein-losing enteropathy. J Paediatr Gastroenterol Nutr 1992;15:404–7.